Efficacy and safety of adjuvant EGFR-TKIs for resected non-small cell lung cancer: a systematic review and meta-analysis based on randomized control trials | BMC Cancer User montaukwhaler, in the non small cell lung cancer subreddit, 01 Apr 2022